在喘中过度依赖短效β-agonists (SABA):一个混合方法研究,在初级保健,在希腊
Izolde Bouloukaki1, Antonios Christodoulakis1, Siân Williams2
1Department of Social Medicine, School of Medicine, University of Crete, Heraklion, CR, Greece.
NPJ primary care respiratory medicine
|November 25, 2025
概括
过度依赖短效β-激动剂 (SABAs) 与喘控制不良有关. 缓解器依赖测试 (RRT) 有效地识别风险患者,帮助制定更好的喘管理策略.
科学领域:
- 肺部病理学 肺部病理学
- 主要护理医学 医疗保健
- 临床研究 临床研究
背景情况:
- 过度依赖短效β-激动剂 (SABAs) 是喘控制不良和死亡率增加的已知危险因素.
- 识别和解决SABA过度依赖对于改善患者结果至关重要.
研究的目的:
- 评估SABA在初级保健喘患者中的过度依赖.
- 为了评估SABA过度依赖和喘控制之间的关联.
- 确定缓解依赖测试 (RRT) 在识别SABA过度依赖方面的实用性和适用性.
主要方法:
- 一项横截面研究,结合了希腊喘患者的定量和定性数据.
- 参与者完成了喘控制测试 (ACT) 和RRT.
- 定性调查评估了患者和全科医生 (GP) 对RRT适用性的反.
主要成果:
- 82%完成RRT的患者有过度依赖SABA的中高风险;24%报告过度使用 (≥3次/周).
- 较差的喘控制显著增加,与更大的SABA依赖和频率 (OR:20.209,p=0.011).
- RRT表现出良好的可靠性 (克朗巴赫α 0.835) 和有效性;患者和全科医生认为它是可以接受和有用的.
结论:
- 过度依赖SABA显著与喘控制不良有关.
- RRT是一个可靠和有效的工具,用于识别SABA在初级保健中的过度依赖.
- 该RRT可以促进有针对性的策略和协作患者-GP讨论,以获得最佳的喘管理.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.5K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.5K
Inhaled Medications
702
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
702


